Availability of an Environmental Assessment for Field Testing Escherichia Coli Vaccine, Live Culture, 24498-24499 [05-9281]
Download as PDF
24498
Notices
Federal Register
Vol. 70, No. 89
Tuesday, May 10, 2005
This section of the FEDERAL REGISTER
contains documents other than rules or
proposed rules that are applicable to the
public. Notices of hearings and investigations,
committee meetings, agency decisions and
rulings, delegations of authority, filing of
petitions and applications and agency
statements of organization and functions are
examples of documents appearing in this
section.
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. 04–126–2]
National Wildlife Services Advisory
Committee; Notice of Solicitation for
Membership
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of solicitation for
membership.
AGENCY:
SUMMARY: The Secretary of Agriculture
has renewed the National Wildlife
Services Advisory Committee for a 2year period. Through this notice, the
Secretary is soliciting nominations for
membership on this Committee.
DATES: Consideration will be given to
nominations received on or before June
24, 2005.
ADDRESSES: Nominations should be
addressed to the person listed under FOR
FURTHER INFORMATION CONTACT.
FOR FURTHER INFORMATION CONTACT: Ms.
Joanne Garrett, Director, Operational
Support Staff, WS, APHIS, 4700 River
Road Unit 87, Riverdale, MD 20737–
1234; (301) 734–7921.
SUPPLEMENTARY INFORMATION: The
National Wildlife Services Advisory
Committee (the Committee) advises the
Secretary of Agriculture on policies,
program issues, and research needed to
conduct the Wildlife Services program.
The committee also serves as a public
forum enabling those affected by the
Wildlife Services program to have a
voice in the program’s policies. The
Committee Chairperson and Vice
Chairperson shall be elected by the
Committee from among its members.
Terms will expire for the current
members of the Committee in July 2005.
We are soliciting nominations from
interested organizations and individuals
to replace members on the Committee.
An organization may nominate
VerDate jul<14>2003
16:17 May 09, 2005
Jkt 205001
individuals from within or outside its
membership. The Secretary will select
members to obtain the broadest possible
representation on the Committee, in
accordance with the Federal Advisory
Committee Act (5 U.S.C. App. II) and
U.S. Department of Agriculture (USDA)
Regulation 1041–1. Equal opportunity
practices, in line with the USDA
policies, will be followed in all
appointments to the Committee. To
ensure that the recommendations of the
Committee have taken into account the
needs of the diverse groups served by
the Department, membership should
include, to the extent practicable,
individuals with demonstrated ability to
represent minorities, women, and
persons with disabilities.
Done in Washington, DC, this 5th day of
May 2005.
W. Ron DeHaven,
Administrator, Animal and Plant Health
Inspection Service.
[FR Doc. 05–9280 Filed 5–9–05; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. 05–034–1]
Availability of an Environmental
Assessment for Field Testing
Escherichia Coli Vaccine, Live Culture
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice of availability and
request for comments.
AGENCY:
SUMMARY: We are advising the public
that the Animal and Plant Health
Inspection Service has prepared an
environmental assessment concerning
authorization to ship for the purpose of
field testing, and then to field test, an
unlicensed Escherichia Coli Vaccine,
Live Culture for use in chickens. The
environmental assessment, which is
based on a risk analysis prepared to
assess the risks associated with the field
testing of this vaccine, examines the
potential effects that field testing this
veterinary vaccine could have on the
quality of the human environment.
Based on the risk analysis, we have
reached a preliminary determination
that field testing this veterinary vaccine
will not have a significant impact on the
PO 00000
Frm 00001
Fmt 4703
Sfmt 4703
quality of the human environment, and
that an environmental impact statement
need not be prepared. We intend to
authorize shipment of this vaccine for
field testing following the close of the
comment period for this notice unless
new substantial issues bearing on the
effects of this action are brought to our
attention. We also intend to issue a U.S.
Veterinary Biological Product license for
this vaccine, provided the field test data
support the conclusions of the
environmental assessment and the
issuance of a finding of no significant
impact and the product meets all other
requirements for licensing.
DATES: We will consider all comments
that we receive on or before June 9,
2005.
ADDRESSES: You may submit comments
by either of the following methods:
• EDOCKET: Go to https://
www.epa.gov/feddocket to submit or
view public comments, access the index
listing of the contents of the official
public docket, and to access those
documents in the public docket that are
available electronically. Once you have
entered EDOCKET, click on the ‘‘View
Open APHIS Dockets’’ link to locate this
document.
• Postal Mail/Commercial Delivery:
Please send four copies of your
comment (an original and three copies)
to: Docket No. 05–034–1, Regulatory
Analysis and Development, PPD,
APHIS, Station 3C71, 4700 River Road
Unit 118, Riverdale, MD 20737–1238.
Please state that your comment refers to
Docket No. 05–034–1.
Reading Room: You may read the
environmental assessment, the risk
analysis (with confidential business
information removed), and any
comments that we receive in our
reading room. The reading room is
located in room 1141 of the USDA
South Building, 14th Street and
Independence Avenue, SW.,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 690–2817 before
coming.
Other Information: You may view
APHIS documents published in the
Federal Register and related
information on the Internet at https://
www.aphis.usda.gov/ppd/rad/
webrepor.html.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\10MYN1.SGM
10MYN1
Federal Register / Vol. 70, No. 89 / Tuesday, May 10, 2005 / Notices
Dr. Albert P. Morgan, Chief Staff
Officer, Operational Support Section,
Center for Veterinary Biologics, Policy,
Evaluation, and Licensing, VS, APHIS,
4700 River Road Unit 148, Riverdale,
MD 20737–1231; phone (301) 734–8245,
fax (301) 734–4314.
For information regarding the
environmental assessment or the risk
analysis, or to request a copy of the
environmental assessment (as well as
the risk analysis with confidential
business information removed), contact
Dr. Patricia L. Foley, Risk Manager,
Center for Veterinary Biologics, Policy,
Evaluation, and Licensing, VS, APHIS,
510 South 17th Street, Suite 104, Ames,
IA 50010; phone (515) 232–5785, fax
(515) 232–7120.
SUPPLEMENTARY INFORMATION: Under the
Virus-Serum-Toxin Act (21 U.S.C. 151
et seq.), a veterinary biological product
must be shown to be pure, safe, potent,
and efficacious before a veterinary
biological product license may be
issued. A field test is generally
necessary to satisfy prelicensing
requirements for veterinary biological
products. Prior to conducting a field test
on an unlicensed product, an applicant
must obtain approval from the Animal
and Plant Health Inspection Service
(APHIS), as well as obtain APHIS’
authorization to ship the product for
field testing.
To determine whether to authorize
shipment and grant approval for the
field testing of the unlicensed product
referenced in this notice, APHIS
conducted a risk analysis to assess the
potential effects of this product on the
safety of animals, public health, and the
environment. Based on the risk analysis,
APHIS has prepared an environmental
assessment (EA) concerning the field
testing of the following unlicensed
veterinary biological product:
Requester: Fort Dodge Animal Health.
Product: Escherichia Coli Vaccine,
Live Culture.
Field Test Locations: Delaware,
Maryland, Georgia, Virginia, and
Arkansas.
The above-mentioned product is a
live aroA gene-deleted Escherichia Coli
Vaccine. The vaccine is for use in
chickens as an aid in the prevention of
disease caused by Escherichia coli.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provision
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
VerDate jul<14>2003
16:17 May 09, 2005
Jkt 205001
Implementing Procedures (7 CFR part
372).
Unless substantial issues with adverse
environmental impacts are raised in
response to this notice, APHIS intends
to issue a finding of no significant
impact (FONSI) based on the EA and
authorize shipment of the above product
for the initiation of field tests following
the close of the comment period for this
notice.
Because the issues raised by field
testing and by issuance of a license are
identical, APHIS has concluded that the
EA that is generated for field testing
would also be applicable to the
proposed licensing action. Provided that
the field test data support the
conclusions of the original EA and the
issuance of a FONSI, APHIS does not
intend to issue a separate EA and FONSI
to support the issuance of the product
license, and would determine that an
environmental impact statement need
not be prepared. APHIS intends to issue
a veterinary biological product license
for this vaccine following completion of
the field test provided no adverse
impacts on the human environment are
identified and provided the product
meets all other requirements for
licensing.
Authority: 21 U.S.C. 151–159; 7 CFR 2.22,
2.80, and 371.4.
Done in Washington, DC, this 4th day of
May 2005.
Elizabeth E. Gaston,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 05–9281 Filed 5–9–05; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF AGRICULTURE
Forest Service
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
Notice of Intent To Prepare an
Environmental Impact Statement for
the Sawtooth National Forest, Idaho;
Twin Falls BLM District, ID; Bald
Mountain Ski Resort Master
Development Plan
AGENCIES: Forest Service, Agriculture,
Lead Agency; Bureau of Land
Management, Interior, Cooperating
Agency.
ACTION: Notice of intent.
SUMMARY: Pursuant to the National
Environmental Policy Act of 1969
(NEPA) and the Federal Land Policy and
Management Act of 1976 (FLPMA), the
USDA Forest Service (Lead Agency) and
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
24499
the USDOI Bureau of Land Management
(Cooperating Agency) intend to prepare
an Environmental Impact Statement
(EIS) to analyze and disclose the effects
of the updated Bald Mountain Ski Area
Master Development Plan (MDP) and
40-year term ski area permit application.
Both agencies have authority over the
Bald Mountain ski area, which is also
known as the Sun Valley Ski Resort.
DATES: Written comments concerning
the proposed action should be
postmarked by June 9, 2005. The draft
environmental impact statement is
expected to be available for public
review and comment in July 2006 and
the final environmental impact
statement is expected to be available
March 2007.
ADDRESSES: Written comments should
be sent to Kurt Nelson, District Ranger
at the Ketchum Ranger Station; P.O. Box
2356, Ketchum, ID 83340. Faxes should
be sent to 208–622–3923 and e-mails to:
comments-intermtn-sawtoothketchum@fs.fed.us. Comments received
on this proposal, including names and
addresses, will be considered part of the
public record and will be available for
public inspection. Individual
respondents may request
confidentiality. If you wish to withhold
your name or street address from public
review or from disclosure under the
Freedom of Information Act, you must
state this prominently at the beginning
of your written comment. Such requests
will be honored to the extent allowed by
law. All submissions from organizations
and businesses, and from individuals
identifying themselves as
representatives or officials of
organizations or businesses, will be
available for public inspection in their
entirety.
FOR FURTHER INFORMATION CONTACT: Joe
Miczulski, Winter Sports Manager at the
Ketchum Ranger District; P.O. Box 2356,
Ketchum, ID 83340; or phone at (208)
622–5371.
SUPPLEMENTARY INFORMATION: Sun
Valley Company has requested a new
40-year term ski area permit for the Bald
Mountain Ski Resort. The existing ski
area permit, which was issued in
December 1977, expires December 2007.
One requirement for a ski area permit is
to have an approved Master
Development Plan (MDP), which is
prepared by the permit holder and
encompasses the entire winter sports
resort envisioned for development and
authorization by the permit. Upon
acceptance by the Authorized Officers,
the MDP becomes part of the ski area
permit. The EIS will analyze the effects
of the proposed action and alternatives.
The agencies give notice of the National
E:\FR\FM\10MYN1.SGM
10MYN1
Agencies
[Federal Register Volume 70, Number 89 (Tuesday, May 10, 2005)]
[Notices]
[Pages 24498-24499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9281]
-----------------------------------------------------------------------
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. 05-034-1]
Availability of an Environmental Assessment for Field Testing
Escherichia Coli Vaccine, Live Culture
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice of availability and request for comments.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared an environmental assessment concerning
authorization to ship for the purpose of field testing, and then to
field test, an unlicensed Escherichia Coli Vaccine, Live Culture for
use in chickens. The environmental assessment, which is based on a risk
analysis prepared to assess the risks associated with the field testing
of this vaccine, examines the potential effects that field testing this
veterinary vaccine could have on the quality of the human environment.
Based on the risk analysis, we have reached a preliminary determination
that field testing this veterinary vaccine will not have a significant
impact on the quality of the human environment, and that an
environmental impact statement need not be prepared. We intend to
authorize shipment of this vaccine for field testing following the
close of the comment period for this notice unless new substantial
issues bearing on the effects of this action are brought to our
attention. We also intend to issue a U.S. Veterinary Biological Product
license for this vaccine, provided the field test data support the
conclusions of the environmental assessment and the issuance of a
finding of no significant impact and the product meets all other
requirements for licensing.
DATES: We will consider all comments that we receive on or before June
9, 2005.
ADDRESSES: You may submit comments by either of the following methods:
EDOCKET: Go to https://www.epa.gov/feddocket to submit or
view public comments, access the index listing of the contents of the
official public docket, and to access those documents in the public
docket that are available electronically. Once you have entered
EDOCKET, click on the ``View Open APHIS Dockets'' link to locate this
document.
Postal Mail/Commercial Delivery: Please send four copies
of your comment (an original and three copies) to: Docket No. 05-034-1,
Regulatory Analysis and Development, PPD, APHIS, Station 3C71, 4700
River Road Unit 118, Riverdale, MD 20737-1238. Please state that your
comment refers to Docket No. 05-034-1.
Reading Room: You may read the environmental assessment, the risk
analysis (with confidential business information removed), and any
comments that we receive in our reading room. The reading room is
located in room 1141 of the USDA South Building, 14th Street and
Independence Avenue, SW., Washington, DC. Normal reading room hours are
8 a.m. to 4:30 p.m., Monday through Friday, except holidays. To be sure
someone is there to help you, please call (202) 690-2817 before coming.
Other Information: You may view APHIS documents published in the
Federal Register and related information on the Internet at https://
www.aphis.usda.gov/ppd/rad/webrepor.html.
FOR FURTHER INFORMATION CONTACT:
[[Page 24499]]
Dr. Albert P. Morgan, Chief Staff Officer, Operational Support
Section, Center for Veterinary Biologics, Policy, Evaluation, and
Licensing, VS, APHIS, 4700 River Road Unit 148, Riverdale, MD 20737-
1231; phone (301) 734-8245, fax (301) 734-4314.
For information regarding the environmental assessment or the risk
analysis, or to request a copy of the environmental assessment (as well
as the risk analysis with confidential business information removed),
contact Dr. Patricia L. Foley, Risk Manager, Center for Veterinary
Biologics, Policy, Evaluation, and Licensing, VS, APHIS, 510 South 17th
Street, Suite 104, Ames, IA 50010; phone (515) 232-5785, fax (515) 232-
7120.
SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C.
151 et seq.), a veterinary biological product must be shown to be pure,
safe, potent, and efficacious before a veterinary biological product
license may be issued. A field test is generally necessary to satisfy
prelicensing requirements for veterinary biological products. Prior to
conducting a field test on an unlicensed product, an applicant must
obtain approval from the Animal and Plant Health Inspection Service
(APHIS), as well as obtain APHIS' authorization to ship the product for
field testing.
To determine whether to authorize shipment and grant approval for
the field testing of the unlicensed product referenced in this notice,
APHIS conducted a risk analysis to assess the potential effects of this
product on the safety of animals, public health, and the environment.
Based on the risk analysis, APHIS has prepared an environmental
assessment (EA) concerning the field testing of the following
unlicensed veterinary biological product:
Requester: Fort Dodge Animal Health.
Product: Escherichia Coli Vaccine, Live Culture.
Field Test Locations: Delaware, Maryland, Georgia, Virginia, and
Arkansas.
The above-mentioned product is a live aroA gene-deleted Escherichia
Coli Vaccine. The vaccine is for use in chickens as an aid in the
prevention of disease caused by Escherichia coli.
The EA has been prepared in accordance with: (1) The National
Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on Environmental Quality for
implementing the procedural provision of NEPA (40 CFR parts 1500-1508),
(3) USDA regulations implementing NEPA (7 CFR part 1b), and (4) APHIS'
NEPA Implementing Procedures (7 CFR part 372).
Unless substantial issues with adverse environmental impacts are
raised in response to this notice, APHIS intends to issue a finding of
no significant impact (FONSI) based on the EA and authorize shipment of
the above product for the initiation of field tests following the close
of the comment period for this notice.
Because the issues raised by field testing and by issuance of a
license are identical, APHIS has concluded that the EA that is
generated for field testing would also be applicable to the proposed
licensing action. Provided that the field test data support the
conclusions of the original EA and the issuance of a FONSI, APHIS does
not intend to issue a separate EA and FONSI to support the issuance of
the product license, and would determine that an environmental impact
statement need not be prepared. APHIS intends to issue a veterinary
biological product license for this vaccine following completion of the
field test provided no adverse impacts on the human environment are
identified and provided the product meets all other requirements for
licensing.
Authority: 21 U.S.C. 151-159; 7 CFR 2.22, 2.80, and 371.4.
Done in Washington, DC, this 4th day of May 2005.
Elizabeth E. Gaston,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 05-9281 Filed 5-9-05; 8:45 am]
BILLING CODE 3410-34-P